China Universal Asset Management Company’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69K | Buy |
72,943
+434
| +0.6% | +$410 | 0.01% | 393 |
|
|
2025
Q1 | $33.4K | Sell |
72,509
-4,141
| -5% | -$1.91K | ﹤0.01% | 441 |
|
|
2024
Q4 | $56.6K | Buy |
76,650
+7,123
| +10% | +$5.26K | 0.01% | 444 |
|
|
2024
Q3 | $109K | Buy |
69,527
+27,058
| +64% | +$42.5K | 0.01% | 351 |
|
|
2024
Q2 | $71.3K | Sell |
42,469
-4,461
| -10% | -$7.49K | 0.01% | 325 |
|
|
2024
Q1 | $113K | Buy |
46,930
+18,601
| +66% | +$44.6K | 0.01% | 363 |
|
|
2023
Q4 | $43.3K | Buy |
28,329
+22,043
| +351% | +$33.7K | 0.01% | 381 |
|
|
2023
Q3 | $6.85K | Buy |
6,286
+3,801
| +153% | +$4.14K | ﹤0.01% | 370 |
|
|
2023
Q2 | $5.69K | Sell |
2,485
-72
| -3% | -$165 | ﹤0.01% | 359 |
|
|
2023
Q1 | $6.21K | Buy |
2,557
+639
| +33% | +$1.55K | ﹤0.01% | 344 |
|
|
2022
Q4 | $3.66K | Buy |
1,918
+199
| +12% | +$380 | ﹤0.01% | 334 |
|
|
2022
Q3 | $4K | Buy |
+1,719
| New | +$4K | ﹤0.01% | 304 |
|